Viatris Inc. (VTRS)

US — Healthcare Sector
Peers: CTLT  BHC  MNK  TLRY  TAK  ELAN  ZTS  EBS  TEVA  LNTH  HLN  RDY  HCM 

Automate Your Wheel Strategy on VTRS

With Tiblio's Option Bot, you can configure your own wheel strategy including VTRS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol VTRS
  • Rev/Share 12.0069
  • Book/Share 13.1251
  • PB 0.6552
  • Debt/Equity 0.9238
  • CurrentRatio 1.6822
  • ROIC -0.0935

 

  • MktCap 10093648000.0
  • FreeCF/Share 1.5592
  • PFCF 5.429
  • PE -2.7056
  • Debt/Assets 0.3758
  • DivYield 0.0558
  • ROE -0.206

 

  • Rating
  • Score
  • Recommendation
  • P/E Score
  • DCF Score
  • P/B Score
  • D/E Score

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

NASDAQ: VTRS INVESTOR ALERT: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors of a June 3, 2025 Deadline
VTRS
Published: April 21, 2025 by: PRNewsWire
Sentiment: Neutral

PHILADELPHIA , April 21, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) on behalf of purchasers of Viatris securities between August 8, 2024 through February 26, 2025, inclusive (the "Class Period"). Investor Deadline: Investors who purchased or acquired Viatris securities during the Class Period may, no later than JUNE 3, 2025 , seek to be appointed as a lead plaintiff representative of the class.

Read More
image for news NASDAQ: VTRS INVESTOR ALERT: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors of a June 3, 2025 Deadline
VTRS LEGAL REMINDER: Did Viatris Inc. Commit Securities Fraud? Contact BFA Law before June 3 Court Deadline (NASDAQ:VTRS)
VTRS
Published: April 21, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Viatris, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/viatris-inc.

Read More
image for news VTRS LEGAL REMINDER: Did Viatris Inc. Commit Securities Fraud? Contact BFA Law before June 3 Court Deadline (NASDAQ:VTRS)
VTRS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Viatris Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
VTRS
Published: April 21, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / April 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Viatris Inc. ("Viatris" or "the Company") (NASDAQ:VTRS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Viatris securities between August 8, 2024 and February 26, 2025, both dates inclusive (the "Class Period").

Read More
image for news VTRS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Viatris Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
Viatris Files Supplemental New Drug Applications to Japan's Ministry of Health, Labor and Welfare for the Approval of EFFEXOR® for the Treatment of Generalized Anxiety Disorder
VTRS
Published: April 21, 2025 by: PRNewsWire
Sentiment: Neutral

Aiming to address a significant unmet need for which no other approved treatment option is available for generalized anxiety disorder patients in Japan PITTSBURGH , April 21, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it has filed applications to the Ministry of Health, Labor and Welfare (MHLW) for approval of Effexor SR Capsules (venlafaxine hydrochloride), a serotonin-noradrenaline reuptake inhibitor (SNRI) to treat adults with generalized anxiety disorder (GAD), an indication for which no other treatment option is currently approved in Japan. As previously announced, our Phase 3 placebo-controlled, randomized, double-blind, multicenter study of venlafaxine …

Read More
image for news Viatris Files Supplemental New Drug Applications to Japan's Ministry of Health, Labor and Welfare for the Approval of EFFEXOR® for the Treatment of Generalized Anxiety Disorder
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Inc. Lawsuit - VTRS
VTRS
Published: April 21, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , April 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Viatris Inc. (NASDAQ: VTRS). Shareholders who purchased shares of VTRS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Read More
image for news The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Inc. Lawsuit - VTRS
Shareholders of Viatris Inc. Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS
VTRS
Published: April 20, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 20, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=144110&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Shareholders of Viatris Inc. Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS
Class Action Filed Against Viatris Inc. (VTRS) - June 3, 2025 Deadline to Join - Contact Levi & Korsinsky
VTRS
Published: April 18, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 18, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=143911&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Class Action Filed Against Viatris Inc. (VTRS) - June 3, 2025 Deadline to Join - Contact Levi & Korsinsky
Viatris Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS
VTRS
Published: April 18, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 18, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=143797&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Viatris Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS
Levi & Korsinsky Notifies Viatris Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - VTRS
VTRS
Published: April 17, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 17, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=143674&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Notifies Viatris Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - VTRS
Lost Money on Viatris Inc.(VTRS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
VTRS
Published: April 17, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 17, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=143653&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Lost Money on Viatris Inc.(VTRS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Levi & Korsinsky Notifies Shareholders of Viatris Inc. (VTRS) of a Class Action Lawsuit and an Upcoming Deadline
VTRS
Published: April 17, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 17, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=143647&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Notifies Shareholders of Viatris Inc. (VTRS) of a Class Action Lawsuit and an Upcoming Deadline
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
VTRS
Published: April 16, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 16, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ:VTRS) between August 8, 2024 and February 26, 2025, both dates inclusive (the "Class Period"), of the important June 3, 2025 lead plaintiff deadline. SO WHAT: If you purchased Viatris securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Read More
image for news ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
Viatris Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS
VTRS
Published: April 16, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 16, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=143446&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Viatris Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS
Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
VTRS
Published: April 16, 2025 by: PRNewsWire
Sentiment: Neutral

BENSALEM, Pa. , April 16, 2025 /PRNewswire/ -- The Law Offices of Howard G.

Read More
image for news Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Shareholders That Lost Money on Viatris Inc. (VTRS) Should Contact Levi & Korsinsky About Pending Class Action - VTRS
VTRS
Published: April 16, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 16, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=143401&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Shareholders That Lost Money on Viatris Inc. (VTRS) Should Contact Levi & Korsinsky About Pending Class Action - VTRS
Investors in Viatris Inc. Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS
VTRS
Published: April 15, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 15, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=143195&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Investors in Viatris Inc. Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS
VTRS LAWSUIT ALERT: Levi & Korsinsky Notifies Viatris Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
VTRS
Published: April 15, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 15, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=143166&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news VTRS LAWSUIT ALERT: Levi & Korsinsky Notifies Viatris Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
STOCKHOLDER ALERT: Pending Securities Fraud Lawsuit Against Viatris (NASDAQ: VTRS)
VTRS
Published: April 15, 2025 by: GlobeNewsWire
Sentiment: Neutral

PHILADELPHIA, April 15, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Viatris Inc. (“Viatris” or the “Company”) (NASDAQ: VTRS) on behalf of purchasers of Viatris securities between August 8, 2024 through February 26, 2025, inclusive (the “Class Period”).

Read More
image for news STOCKHOLDER ALERT: Pending Securities Fraud Lawsuit Against Viatris (NASDAQ: VTRS)
Lost Money on Viatris Inc. (VTRS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
VTRS
Published: April 15, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 15, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=143158&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Lost Money on Viatris Inc. (VTRS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS
VTRS
Published: April 15, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Viatris, Inc. ("Viatris" or the "Company") (NASDAQ:VTRS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS
Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
VTRS
Published: April 14, 2025 by: PRNewsWire
Sentiment: Neutral

LOS ANGELES , April 14, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) have opportunity to lead the securities fraud class action lawsuit.

Read More
image for news Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
VTRS LAWSUIT ALERT: Levi & Korsinsky Notifies Viatris Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
VTRS
Published: April 14, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=142935&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news VTRS LAWSUIT ALERT: Levi & Korsinsky Notifies Viatris Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm
VTRS
Published: April 14, 2025 by: PRNewsWire
Sentiment: Neutral

LOS ANGELES , April 14, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Viatris Inc. ("Viatris" or "the Company") (NASDAQ: VTRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 8, 2024 and February 26, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before June 3, 2025.

Read More
image for news VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm
Class Action Filed Against Viatris Inc. (VTRS) - June 3, 2025 Deadline to Join - Contact Levi & Korsinsky
VTRS
Published: April 11, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=142561&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Class Action Filed Against Viatris Inc. (VTRS) - June 3, 2025 Deadline to Join - Contact Levi & Korsinsky
Contact Levi & Korsinsky by June 3, 2025 Deadline to Join Class Action Against Viatris Inc.(VTRS)
VTRS
Published: April 11, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=142547&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Contact Levi & Korsinsky by June 3, 2025 Deadline to Join Class Action Against Viatris Inc.(VTRS)
Viatris Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS
VTRS
Published: April 11, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=142541&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Viatris Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS
VIATRIS INC. (NASDAQ: VTRS) INVESTOR ALERT: Investors With Large Losses in Viatris Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
VTRS
Published: April 11, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / April 11, 2025 / VIATRIS INC. (NASDAQ: VTRS)INVESTOR ALERT: Investors With Large Losses in Viatris Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the "Class") who purchased or acquired the securities of Viatris, Inc. ("Viatris" or the "Company") (NASDAQ:VTRS) between August 8, 2024 and February 26, 2025, inclusive.

Read More
image for news VIATRIS INC. (NASDAQ: VTRS) INVESTOR ALERT: Investors With Large Losses in Viatris Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
VTRS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
VTRS
Published: April 10, 2025 by: Business Wire
Sentiment: Neutral

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Viatris business and prospects, resulting in its stock trading at inflated prices.

Read More
image for news VTRS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Levi & Korsinsky Reminds Viatris Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - VTRS
VTRS
Published: April 10, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 10, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=142315&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Reminds Viatris Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - VTRS
Class Action Filed Against Viatris Inc. (VTRS) Seeking Recovery for Investors - Contact Levi & Korsinsky
VTRS
Published: April 10, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 10, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=142299&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Class Action Filed Against Viatris Inc. (VTRS) Seeking Recovery for Investors - Contact Levi & Korsinsky

About Viatris Inc. (VTRS)

  • IPO Date 1980-03-17
  • Website https://www.viatris.com
  • Industry Drug Manufacturers - Specialty & Generic
  • CEO Mr. Scott Andrew Smith Ph.D.
  • Employees 32000

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.